Pharma & Health Insider
Recent reports explain how gun makers target kids -- and how Purdue's opioid competitors picked up the slack after the lawsuits began. Read the whole story
The Cormirnaty and Paxlovid declines were even steeper than Pfizer had been expecting. Vaccine revenues declined $3.1 billion YoY, down 70%. Read the whole story
Both heavily advertised, Skyrizi's net revenues increased 52.1% YOY to $2.16 billion, while Rinvoq's rose 59.8% to $1.1 billion. Read the whole story
The message proved too much for the three leading national out-of-home (OOH) companies, anti-dairy nonprofit Switch4Good tells "Marketing Daily." Read the whole story
Eric Trott, Premera Blue Cross VP, referred to "a more human approach" as opposed to other health plans "promoting table stakes attributes." Read the whole story
'Well Actually' will feature content on a variety of issues, including green living, food and mental health. Read the whole story
Third-quarter results for the ecommerce giant topped expectations, with ad sales climbing to $12 billion. Read the whole story
